Vinati Organics Q3FY25 results: Revenue rises 16.5% YoY to Rs 521.68 crore, net profit up 21.7% to Rs 93.58 crore
The company maintained a strong earnings per share (EPS), with basic and diluted EPS at ₹9.04 for Q3FY25, compared to ₹7.42 in Q3FY24.
Matrika Shukla, Beat Editor at Business Upturn, is a Multimedia student. She is passionate about investigating and reporting on complex subjects. She has an extensive background in digital media with special focus on Politics.
The company maintained a strong earnings per share (EPS), with basic and diluted EPS at ₹9.04 for Q3FY25, compared to ₹7.42 in Q3FY24.
The incident occurred at approximately 9:30 AM during the construction of the preheater unit as part of the company’s Panna Line-2 expansion project.
Core insurance revenue grew 45% YoY, driven by health insurance outpacing other segments. The renewal/trail revenue reached an annualized run rate (ARR) of ₹665 crore, marking a 46% increase from ₹454 crore in Q3 FY24.
The company’s consolidated revenue from operations for the quarter ended December 31, 2024, stood at ₹7,288.84 crore, marking a substantial increase from ₹5,223.08 crore in the same quarter of the previous year.
PPL’s investment will be focused on increasing the phosphatic fertilizer manufacturing capacity, both for intermediate and final products. It will also support Port/Jetty and infrastructure development at the Paradeep facility.
This significant growth reflects TCPL’s strategic focus on expanding its product portfolio, enhancing operational efficiencies, and leveraging strong brand positioning in the market.
For the quarter ending December 31, 2024, Indegene posted a consolidated net profit of ₹110 crore, compared to ₹99 crore in Q3 FY24.
The company’s standalone investments primarily comprise equity holdings in Bajaj Auto, Bajaj Finserv, and Maharashtra Scooters, along with other financial investments exceeding ₹15,000 crore in market value.
The new venture will focus on the construction, operation, and maintenance of CBG plants throughout India, in addition to the sale of CBG and its derivatives.
L&T has registered the highest-ever quarterly order inflow of ₹1,16,036 crore in Q3FY25, marking a 53% year-on-year growth. This increase has been driven by multiple sectors, including Thermal Power, Renewable Energy, and Hydrocarbons, contributing significantly to the overall success.
The bank reported a 5.6% YoY increase in its net profit for Q3FY25, reaching INR 4,837 crore, and a 12.6% rise in net profit for the nine months of FY25, amounting to INR 14,533 crore.
With a solid financial performance in the first nine months of FY 2024-25, Astral Limited remains optimistic about the future. The company is focusing on strategic investments, new product launches, and further expansion into international markets to sustain its growth momentum.
Profit after tax (PAT) stood at ₹411.04 million for Q3 FY2024-25, and ₹1,791.16 million for the nine months, marking a solid growth trajectory.
The company also disclosed that the consolidated results include financials from its international subsidiaries, including Manchester Organics Limited, NFIL (UK) Limited, and Navin Fluorine (Shanghai) Co. Limited, among others.
According to IQVIA MAT December 2024 data, Ajanta Pharma’s India growth was 11%, outpacing the Indian Pharmaceutical Market (IPM) growth of 8%.
Showing 165 of 661 articles